Clinical Trials on Neoplastic Processes

Conditions: Breast Carcinoma; Digestive System Neoplasm; Malignant Brain Neoplasm; Malignant Central Nervous System Neoplasm; Malignant Female Reproductive System Neoplasm; Malignant Genitourinary System Neoplasm; Malignant Head and Neck Neoplasm; Malignant Musculoskeletal Neoplasm; Malignant Solid Neoplasm; Metastatic Malignant Neoplasm of Unknown Primary; Skin Carcinoma

Conditions: Brain Metastases

Conditions: PCNSL; Secondary Central Nervous System Lymphoma

Conditions: Brain Metastases, Adult

Conditions: Pancreas Adenocarcinoma

Conditions: Breast Cancer; Triple Negative Breast Cancer; Residual Cancer; Circulating Tumor DNA

Conditions: Astrocytoma; Brain Cancer; Brain Metastases; Bladder Cancer; Breast Cancer; Cervical Cancer; Cholangiocarcinoma; Colorectal Cancer; Esophagus Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Liver Cancer; Lung Cancer; Melanoma; Ovarian Cancer; Pancreatic Cancer; Pleural Mesothelioma; Prostate Cancer; Sarcoma; Tongue Cancer; Thymic Carcinoma; Urinary Tract Cancer

Conditions: Thyroid Cancer; Thyroid Carcinoma, Papillary; Thyroid Metastases; Thyroid Neoplasms; Sentinel Lymph Node; Lymph Node Metastases

Conditions: Leptomeningeal Metastasis; Non-small Cell Lung Cancer; EGFR Activating Mutation

Conditions: Secondary Caries Around Resin Composite Restorations

Conditions: NSCLC; Lymph Node Metastases

Conditions: Pancreatic Cancer; Liver Metastasis

Conditions: Advanced Breast Cancer; HER2-positive Breast Cancer; Brain Metastases; Leptomeningeal Metastasis

Conditions: Brain Metastases

Conditions: Metastatic Neoplasm

Conditions: Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)

Conditions: Lung Cancer, Nonsmall Cell; Brain Metastases

Conditions: Tumor, Solid; Positron-Emission Tomography; Metastasis

Conditions: KRAS Gene; Colorectal Cancer; Liver Metastasis; Safe Margin; Radiofrequency Ablation

Conditions: Advanced Solid Tumors Cancer

Conditions: Secondary Progressive Multiple Sclerosis

Conditions: Brain Metastases

Conditions: Brain Metastases

Conditions: Solid Tumor; Oligometastases; Soft Tissue Disease

Conditions: Endometrial Cancer; Cervical Cancer; Sentinel Lymph Node; Micrometastasis; Sentinel Lymph Node Biopsy; Endometrium Tumor; Endometrial Neoplasms; Cervical Neoplasm; Cervical Tumor; Lymph Node Metastases; Lymph Node Disease

Conditions: Liver Metastases; Hepatocellular Carcinoma; Bile Duct Cancer

Conditions: ICC; Metastatic Cancer

Conditions: Brain Metastases, Adult

Conditions: Brain Metastases; Radiotherapy Side Effect; Cognitive Impairment; Gangliosidosis, GM1; Breast Cancer

Conditions: Upper Extremity Deep Vein Thrombosis, Secondary

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis

Conditions: Oncology; Spine Metastases

Conditions: Head and Neck Cancer; Soft Tissue Tumor and/or Sarcoma; Neoplasm of Skin; Neoplasm Metastasis; Melanoma

Conditions: Lung Neoplasms; Neoplasm Metastasis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis

Conditions: Brain Metastases

Conditions: Quality of Life; Brain Metastases

Conditions: Bladder Cancer

Conditions: Leptomeningeal Metastasis

Conditions: Leptomeningeal Metastasis; Durvalumab

Conditions: Primary Immune Deficiency Disorder; Secondary Immune Deficiency

Conditions: Brain Metastases, Adult

Conditions: Gastrointestinal Stromal Tumors; Metastasis; Disease Progression

Conditions: Leptomeningeal Metastases

Conditions: Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Conditions: HER2-positive Breast Cancer

Conditions: Carcinoma, Hepatocellular; Biliary Tract Cancer; Secondary Liver Cancer; Liver Metastases

Conditions: Phase II Clinical Trial; Ninety-six Histologically Confirmed NSCLC Patients With BM; Randomized 1:1 to Received TN Plus WBR or Only WBR; ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Conditions: Breast Cancer; Brain Metastases

Conditions: SARS-CoV-2 (COVID-19) Infection; Advanced or Metastatic Hematological or Solid Tumor